MIMIX Trademark

Trademark Overview

On Friday, September 23, 2016, a trademark application was filed for MIMIX with the United States Patent and Trademark Office. The USPTO has given the MIMIX trademark a serial number of 87181775. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 18, 2021. This trademark is owned by Vaxess Technologies, Inc.. The MIMIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, pain relief medication and hormones for medical purposes; vaccines; immunotherapies for the treatment of cancer, autoimmune diseases or disorders, and allergies; drug delivery agents in the form of patches that provide transdermal delivery of the active ingredient for a wide range of pharmaceuticals; drug delivery agents in the form of polymers that facilitate the sustained release of a wide range of pharmaceuticals; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with vaccines; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with immunotherapies for the treatment of cancer, autoimmune diseases or disorders, and allergies; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with pain relief medication; drug delivery a...
mimix

General Information

Serial Number87181775
Word MarkMIMIX
Filing DateFriday, September 23, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 18, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 17, 2017

Trademark Statements

Goods and ServicesPharmaceuticals, namely, pain relief medication and hormones for medical purposes; vaccines; immunotherapies for the treatment of cancer, autoimmune diseases or disorders, and allergies; drug delivery agents in the form of patches that provide transdermal delivery of the active ingredient for a wide range of pharmaceuticals; drug delivery agents in the form of polymers that facilitate the sustained release of a wide range of pharmaceuticals; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with vaccines; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with immunotherapies for the treatment of cancer, autoimmune diseases or disorders, and allergies; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with pain relief medication; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with hormones for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 28, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVaxess Technologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameVaxess Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Tuesday, January 19, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 18, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 13, 2020EXTENSION 5 GRANTED
Wednesday, April 8, 2020EXTENSION 5 FILED
Monday, April 13, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 8, 2020TEAS EXTENSION RECEIVED
Friday, October 4, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 2, 2019EXTENSION 4 GRANTED
Wednesday, October 2, 2019EXTENSION 4 FILED
Wednesday, October 2, 2019TEAS EXTENSION RECEIVED
Friday, March 15, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 13, 2019EXTENSION 3 GRANTED
Wednesday, March 13, 2019EXTENSION 3 FILED
Wednesday, March 13, 2019TEAS EXTENSION RECEIVED
Friday, October 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 10, 2018EXTENSION 2 GRANTED
Wednesday, October 10, 2018EXTENSION 2 FILED
Wednesday, October 10, 2018TEAS EXTENSION RECEIVED
Thursday, March 8, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 6, 2018EXTENSION 1 GRANTED
Tuesday, March 6, 2018EXTENSION 1 FILED
Tuesday, March 6, 2018TEAS EXTENSION RECEIVED
Tuesday, December 12, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 17, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 17, 2017PUBLISHED FOR OPPOSITION
Wednesday, September 27, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 6, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, August 12, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 11, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 11, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 1, 2017ASSIGNED TO EXAMINER
Monday, February 27, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 27, 2017NON-FINAL ACTION E-MAILED
Monday, February 27, 2017NON-FINAL ACTION WRITTEN
Monday, January 23, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 23, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 23, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, December 31, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, December 31, 2016NON-FINAL ACTION E-MAILED
Saturday, December 31, 2016NON-FINAL ACTION WRITTEN
Thursday, December 29, 2016ASSIGNED TO EXAMINER
Wednesday, September 28, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 27, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

mimix delivery pharmaceuticals drug form agents transdermal facilitate microneedles filled resorbable